Sheehan's syndrome and its impact on bone mineral density

Gynecological Endocrinology

Volumn 25, Issue 5, 2009, Pages 344-349

  Gokalp, Deniz ^a   Tuzcu, Alpaslan ^a   Bahceci, Mithat ^a   Arikan, Senay ^a   Ozmen, Cihan Akgul ^a   Cil, Timucin ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bone mineral density; Osteoporosis; PTH; Sheehan's syndrome

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; HYPOPHYSIS HORMONE; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEMUR; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SPINE;

ADULT; AGED; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPOPITUITARISM; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE;

EID: 67651102674     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802630096     Document Type: Article

References (22)

1. Sheehan HL. Postpartum necrosis of the anterior pituitary. J Path Bacteriol 1937;45:189-214.
2. Scheithauer BW, Sano T, Kovacs KT, Young WF Jr, Ryan N, Randall RV. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990;65:461-474.
3. Kovacs K. Sheehan syndrome. Lancet 2003;361:520-522.
4. Dash RJ, Gupta V, Suri S. Sheehan's syndrome: clinical profile, pituitary hormone responses and computed sellar tomography. Aust N Z J Med 1993;23:26-31.
5. Ozbey N, Inanc S, Aral F, Azezli A, Orhan Y, Sencer E, Molvalilar S. Clinical and laboratory evaluation of 40 patients with Sheehan's syndrome. Isr J Med Sci 1994;30:826-829.
6. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646-650.
7. de Boer H, Blok GJ, Van Lingen A, Teule GJ, Lips P, van der Veen EA. The consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 1994;9:1319-1326.
8. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992;74:118-123.
9. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994;78:669-674.
10. Lamberts SW, de Herder WW, van der Lely AJ. Pituitary insufficiency. Lancet 1998;352:127-134.
11. Dokmetas HS, Kilicli F, Korkmaz S, Yonem O. Characteristic features of 20 patients with Sheehan's syndrome. Gynecol Endocrinol 2006;22:279-283.
12. Seeman E, Melton LJ, O'Fallon WM, et al. Risk factors for spinal osteoporosis in men. Am J Med 1983;75:977-983.
13. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997;82:2386-2390.
14. Lees B, Pugh M, Siddle N, Stevenson JC. Changes in bone density in women starting hormone replacement therapy compared with those in women already established on hormone replacement therapy. Osteop Int 1995;5:344-348.
15. de Boer H, Block G-J, Van Der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995; 16:63-86.
16. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999;84:1919-1924.
17. Abs R, Bengtsson B-A, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P, Wüster C. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol 1999;50:703-713.
18. Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P; KIMS Study Group and the KIMS International Board. Pharmacia & Upjohn International Metabolic Database. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001;16:398-405.
19. Monson JP, Drake WM, Carroll PV, Weaver JU, Rodriguez-Arnao J, Savage MO. Influence of growth hormone on accretion of bone mass. Horm Res 2002;58(Suppl 1):52-56.
20. Ahmad AM, Hopkins MT, Fraser WD, Ooi CG, Durham BH, Vora JP. Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency. Bone 2003;32:170-179.
21. Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 1997;350:550-555.
22. Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. J Clin Endocrinol Metab 2003;88:2860-2868.